Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4310487 | 0.98 | LTA4H (0.53) | ALDH1A1LTA4HMAPK1L3MBTL1ALOX5 | |
| SCHEMBL247907 | 0.95 | ALDH1A1 (0.53) | ALDH1A1LTA4HMAPK1L3MBTL1ALOX5 | |
| SCHEMBL19634437 | 0.94 | ALDH1A1 (0.51) | ALDH1A1LTA4HMAPK1L3MBTL1ALOX5 | |
| SCHEMBL27629212 | 0.94 | ALDH1A1 (0.51) | ALDH1A1LTA4HMAPK1L3MBTL1ALOX5 | |
| SCHEMBL13407447 | 0.90 | ALDH1A1 (0.58) | ALDH1A1LTA4HMAPK1L3MBTL1EGFR | |
| SCHEMBL21846519 | 0.88 | ALDH1A1 (0.51) | ALDH1A1LTA4HMAPK1L3MBTL1ALOX5 | |
| SCHEMBL19862467 | 0.87 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1ALOX5LMNA | |
| SCHEMBL10081340 | 0.86 | LTA4H (0.44) | ALDH1A1LTA4HMAPK1L3MBTL1ALOX5 | |
| SCHEMBL21995253 | 0.84 | ALDH1A1 (0.45) | ALDH1A1LTA4HMAPK1L3MBTL1ALOX5 | |
| SCHEMBL8886811 | 0.84 | ALOX5 (0.52) | ALDH1A1MAPK1L3MBTL1ALOX5LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115304-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | BEONE MEDICINES I GMBH (CH) | 2026-04-30 | — | — | US | disclosed |
| EP-4183773-A1 | ZWITTERIONIC REAGENTS | Siemens Healthcare Diagnostics Inc. (US) | 2023-05-24 | — | — | EP | disclosed |
| EP-2571487-B1 | ZWITTERIONIC REAGENTS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2023-01-04 | — | — | EP | disclosed |
| US-20220218852-A1 | NOVEL RADIOLABELLED CXCR4-TARGETING COMPOUNDS FOR DIAGNOSIS AND THERAPY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-07-14 | — | — | US | disclosed |
| US-20220218852-A1 | NOVEL RADIOLABELLED CXCR4-TARGETING COMPOUNDS FOR DIAGNOSIS AND THERAPY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-07-14 | — | — | US | disclosed |
| CN-114364690-A | Novel radiolabeled CXCR4 targeting compounds for diagnosis and therapy | 省卫生服务机构 | 2022-04-15 | — | — | CN | disclosed |
| EP-3956346-A1 | NOVEL RADIOLABELLED CXCR4-TARGETING COMPOUNDS FOR DIAGNOSIS AND THERAPY | Provincial Health Services Authority (CA) | 2022-02-23 | — | — | EP | disclosed |
| WO-2020210919-A1 | NOVEL RADIOLABELLED CXCR4-TARGETING COMPOUNDS FOR DIAGNOSIS AND THERAPY | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2020-10-22 | — | — | WO | disclosed |
| WO-2020210919-A1 | NOVEL RADIOLABELLED CXCR4-TARGETING COMPOUNDS FOR DIAGNOSIS AND THERAPY | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2020-10-22 | — | — | WO | disclosed |
| EP-3288658-B1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING ION PAIRED-BONDED PHASES FOR SUPERCRITICAL FLUID CHROMATOGRAPHY | WATERS TECHNOLOGIES CORP (US) | 2020-08-26 | — | — | EP | disclosed |
| US-8697604-B2 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2014-04-15 | — | — | US | disclosed |
| EP-1606623-B1 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | ELECTROPHORETICS LTD (GB) | 2013-05-22 | — | — | EP | disclosed |
| EP-1606623-B1 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | ELECTROPHORETICS LTD (GB) | 2013-05-22 | — | — | EP | disclosed |
| US-20130065325-A1 | ZWITTERIONIC REAGENTS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2013-03-14 | — | — | US | disclosed |
| WO-2011146595-A2 | ZWITTERIONIC REAGENTS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20070023628-A1 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2007-02-01 | — | — | US | disclosed |
| US-20070023628-A1 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2007-02-01 | — | — | US | disclosed |
| US-20070023628-A1 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2007-02-01 | — | — | US | disclosed |
| EP-1606623-A2 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | Xzillion GmbH & CO.KG (DE) | 2005-12-21 | — | — | EP | disclosed |
| WO-2004086050-A2 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | XZILLION GMBH & CO. KG (DE) | 2004-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220218852-A1 | NOVEL RADIOLABELLED CXCR4-TARGETING COMPOUNDS FOR DIAGNOSIS AND THERAPY | CXCR4, CXCR1, FPR1 | ALDH1A1 3495/4885LTA4H 2888/4885MAPK1 1057/4885 |
| US-20130065325-A1 | ZWITTERIONIC REAGENTS | BTD, HLCS, WIZ | ALDH1A1 4381/4885LTA4H 1433/4885MAPK1 3180/4885 |
| US-20260115304-A1 | BIOACTIVE CONJUGATES, PREPARATION METHOD AND USE THEREOF | GUSB, PSMA6, CD44 | ALDH1A1 516/4885LTA4H 2989/4885MAPK1 3791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.